Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation

被引:112
|
作者
Frick, M [1 ]
Frykman, V
Jensen-Urstad, M
Östergren, J
Rosenqvist, M
机构
[1] South Hosp, Dept Cardiol, S-11883 Stockholm, Sweden
[2] Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden
[3] Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden
关键词
atrial fibrillation; cardioversion; arrhythmias;
D O I
10.1002/clc.4960240313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The recurrence rate of atrial fibrillation (AF) after elective cardioversion is high. Hypothesis: The study aimed to identify clinical predictors for successful electrical cardioversion and maintenance of sinus rhythm after a first electrical cardioversion in patients with persistent AF without concomitant antiarrhythmic drugs of class I and LII. Methods: Consecutive outpatients (n = 166) with persistent AF for > 1 month, scheduled for elective cardioversion, were prospectively included in the study. A clinical investigation, echocardiographic assay, and Kelter electrocardiogram (ECG) before and ECG 4 weeks after cardioversion, were performed in all patients. Results: The mean age of the patients was 68 years (range 45-83) and duration of AF was 5 (1-48) months. Sinus rhythm was established in 124 (75%) patients. In multivariate analysis, only duration of AF < 6 months (p < 0.04, odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1 to 4.7) and patients weight (p <0.03, OR 2.3, 95% CI 1.1 to 4.8 for weight < 80 kg) were identified as independent predictors of successful cardioversion. At 4 weeks after cardioversion, only 46 (37%) of 124 patients maintained sinus rhythm. Independent factors for maintenance of sinus rhythm, in multivariate analysis, were AF <3 months (p<0.04, OR 2.5, 95% CI 1.1 to 5.6), treatment with beta blockers (p < 0.00001, OR 7.0, 95% CI 3.0 to 16.3) or verapamil/diltiazem (p<0.04, OR 3.6, 95% CI 1.1 to 12.1), and right atrial dimension < 37 mm (p < 0.02, OR 5.9, 95% CI 1.4 to 25.4). Conclusions: In patients with persistent AF, the patient's weight and the duration of AF are independent predictors for a successful cardioversion. Short duration of AF, treatment with beta blockers or verapamil/diltiazem, and right atrial area/dimension are independent predictors for maintenance of sinus rhythm.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 50 条
  • [21] Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion
    Naji, Franjo
    Sabovic, Miso
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2011, 10
  • [22] Therapeutic success of a prospective cardioversion protocol for persistent atrial fibrillation
    Martinez-Brotons, Angel M.
    Ruiz-Granell, Ricardo
    Morell, Salvador
    Plancha, Eva
    Ferrero, Angel
    Rosello, Araceli
    Llacer, Angel
    Garcia-Civera, Roberto
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (10): : 1038 - 1046
  • [23] Current aspects of electrical cardioversion in patients with persistent atrial fibrillation
    Mickley, F
    Löscher, S
    Hartmann, A
    MEDIZINISCHE KLINIK, 2004, 99 (01) : 18 - 23
  • [24] The role of HATCH score in predicting the success rate of sinus rhythm following electrical cardioversion of atrial fibrillation
    Emren, Sadik Volkan
    Kocabas, Ugur
    Duygu, Hamza
    Levent, Fatih
    Simsek, Ersin Cagri
    Emren, Zeynep Yapan
    Tuluce, Selcen
    KARDIOLOGIA POLSKA, 2016, 74 (09) : 978 - 984
  • [25] Prediction of atrial fibrillation recurrence after cardioversion in patients with left-atrial dilation
    Fornengo, Cristina
    Antolini, Marina
    Frea, Simone
    Gallo, Cristina
    Marra, Walter Grosso
    Morello, Mara
    Gaita, Fiorenzo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (03) : 335 - 341
  • [26] Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy
    Demir, Kenan
    Can, Ilknur
    Koc, Fatih
    Vatankulu, Mehmet Akif
    Ayhan, Selim
    Akilli, Hakan
    Aribas, Alpay
    Alihanoglu, Yusuf
    Altunkeser, Bulent Behlul
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (05) : 464 - 469
  • [27] Analysis of clinical risk factors of failed electrical cardioversion in patients with persistent atrial fibrillation or atrial flutter
    Ki-Hun Kim
    Ha-Young Choi
    Jino Park
    Yeo-Jeong Song
    Seunghwan Kim
    Dong-Kie Kim
    Sang-Hoon Seol
    Doo-Il Kim
    Pil-Sung Yang
    Hong Euy Lim
    Junbeum Park
    Jae-Min Shim
    Jinhee Ahn
    Sung Ho Lee
    Sung Il Im
    Ju Youn Kim
    International Journal of Arrhythmia, 24 (1)
  • [28] Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion
    Xia, Wei
    Qu, Xiufen
    Yu, Yang
    Zhang, Xueli
    Feng, Wei
    Song, Ying
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (08): : 1036 - 1040
  • [29] Left Atrial Wall Motion Velocity Assessed during Atrial Fibrillation Predicts Sinus Rhythm Maintenance after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation
    Walek, Pawel
    Roskal-Walek, Joanna
    Dlubis, Patryk
    Tracz, Justyna
    Wozakowska-Kaplon, Beata
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [30] Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
    Tveit, Arnljot
    Seljeflot, Ingebjorg
    Grundvold, Irene
    Abdelnoor, Michael
    Arnesen, Harald
    Smith, Pal
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) : 234 - 239